Non Hodgkin Lymphoma News and Research

RSS
High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

Tumor DNA in DLBCL patient's stem cells or blood can predict risk of relapse after transplant

Tumor DNA in DLBCL patient's stem cells or blood can predict risk of relapse after transplant

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A New Therapeutic Target Turns The Immune System Against Lymphoma

A New Therapeutic Target Turns The Immune System Against Lymphoma